neurology
Multiple sclerosis

Lessons from decades of glatiramer acetate

Sponsored by Teva Pharma Australia Pty Ltd

Speaking at Teva Central Nervous System Weekend (TCW 19), key investigator in glatiramer acetate (GA) trials, Professor Andrew Goodman, Professor of Neurology, Chief of the Neuroimmunology Division and Director of the Multiple Sclerosis Center at the University of Rochester and Professor Jeannette Lechner-Scott, Conjoint Professor at the University of Newcastle spoke of their cumulative experience ...

Already a member?

Enter your email to keep reading.


OR